ValiRx plc Financial Flexibility Index
ValiRx plc financial flexibility index. ValiRx plc (VAL) has a Financial Flexibility Index of -1.99x as of December 2024. Free cash flow of £-690.49K (operating CF £-700.73K minus capex £10.25K) represents -2% of total liabilities (£346.41K). See free cash flow generation of ValiRx plc to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ValiRx plc (2001–2024)
Financial flexibility index of ValiRx plc from 2001 to 2024. Historical Financial Flexibility Index trend for ValiRx plc across 25 annual periods. Check VAL cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
ValiRx plc Financial Flexibility Index by Year (2001–2024)
ValiRx plc financial flexibility index by year from 2001 to 2024. Year-by-year free cash flow to debt coverage for ValiRx plc. For the full cash flow conversion analysis, see ValiRx plc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (GBP) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.46x | £-1.55 Million | £-1.58 Million | £346.41K | ▲ +31.0% |
| 2023 | -6.47x | £-1.47 Million | £-1.77 Million | £226.51K | ▲ +43.4% |
| 2022 | -11.44x | £-1.71 Million | £-1.71 Million | £149.65K | ▲ +0.6% |
| 2021 | -11.51x | £-1.26 Million | £-1.26 Million | £109.56K | ▼ -15.5% |
| 2020 | -9.96x | £-1.82 Million | £-1.91 Million | £182.40K | ▼ -1356.8% |
| 2019 | -0.68x | £-944.89K | £-1.34 Million | £1.38 Million | ▲ +72.8% |
| 2018 | -2.52x | £-3.03 Million | £-3.35 Million | £1.20 Million | ▼ -116.8% |
| 2017 | -1.16x | £-2.07 Million | £-2.35 Million | £1.78 Million | ▲ +21.4% |
| 2016 | -1.48x | £-3.83 Million | £-4.22 Million | £2.59 Million | ▲ +59.9% |
| 2015 | -3.68x | £-2.17 Million | £-2.59 Million | £588.55K | ▼ -12.6% |
| 2014 | -3.27x | £-2.73 Million | £-3.01 Million | £835.08K | ▼ -48.2% |
| 2013 | -2.21x | £-1.93 Million | £-2.07 Million | £876.10K | ▲ +68.7% |
| 2012 | -7.06x | £-1.85 Million | £-1.98 Million | £261.63K | ▲ +21.0% |
| 2011 | -8.93x | £-1.26 Million | £-1.46 Million | £141.00K | ▼ -1165.2% |
| 2010 | -0.71x | £-355.00K | £-496.00K | £503.00K | ▲ +37.5% |
| 2009 | -1.13x | £-856.00K | £-926.00K | £758.00K | ▲ +34.7% |
| 2008 | -1.73x | £-707.00K | £-794.00K | £409.00K | ▲ +76.2% |
| 2007 | -7.26x | £-704.00K | £-839.00K | £97.00K | ▼ -1770.5% |
| 2006 | -0.39x | £-40.74K | £-45.77K | £105.00K | ▲ +75.1% |
| 2006 | -1.56x | £-14.00K | £-55.00K | £9.00K | ▼ -406.2% |
| 2005 | -0.31x | £-63.00K | £-63.00K | £205.00K | ▲ +87.7% |
| 2004 | -2.50x | £-225.00K | £-225.00K | £90.00K | ▼ -299.3% |
| 2003 | 1.25x | £74.00K | £74.00K | £59.00K | ▼ -76.0% |
| 2002 | 5.23x | £1.79 Million | £1.77 Million | £343.00K | ▲ +64.2% |
| 2001 | 3.19x | £1.94 Million | £1.91 Million | £609.00K | — |